The current protocol plans to enroll participants with youth-onset Type 2 Diabetes (T2D) as well as obese and lean controls from the Renal-HEIR - Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes Study (n=100) \[COMIRB #16-1752\] in a prospective investigation that seeks to 1) define the changes in kidney function by gold standard techniques and energetics by functional Magnetic Resonance Imaging (MRI) in adolescents with and without T2D as they transition to young adulthood; 2) quantify kidney oxidative metabolism by 11C-acetate Positron Emission Tomography (PET) in a subset of participants who are ≥18 years of age with youth-onset T2D and/or obesity; 3) determine peripheral arterial stiffness by SphygmoCor. Mechanistic insight will be provided by transcriptomic analyses of repeat biopsies 3-years after their initial biopsy for eligible participants with youth-onset T2D, as well as molecular analysis of tissue obtained from J-wire endovascular biopsies. This study will also leverage this well-characterized cohort of youths to define youth-onset T2D-related changes in brain morphology and function by structural MRI and resting-state functional MRI and through the assessment of cognitive function (fluid and crystallized intelligence) using the NIH Toolbox Cognitive Battery (NIHTB-CB), as an exploratory objective. All enrollees in Renal-HEIR have consented to be contacted for future research opportunities.
Study Type
OBSERVATIONAL
Enrollment
100
Diagnostic aid/agent used to measure effective renal plasma flow (ERPF)
Diagnostic aid/agent used to measure glomerular filtration rate (GFR)
Diagnostic aid/agent used to measure glomerular size selectivity
Minimally invasive outpatient procedure in interventional radiology to obtain renal tissue cores.
Imaging study performed to study renal oxidative metabolism
Children's Hospital Colorado
Aurora, Colorado, United States
Effective Renal Plasma Flow (ERPF)
Measured by PAH clearance
Time frame: 4 Hours
Glomerular Filtration Rate
Measured by Iohexol Clearance
Time frame: 4 Hours
Glomerular Size Selectivity
Measured by Dextran sieving
Time frame: 4 hours
Renal Oxygen Availability
Measured by functional kidney MRI
Time frame: 1 hour
Renal Perfusion
Measured by functional kidney MRI + PET Scan
Time frame: 1 hour
11-C Acetate Tracer Uptake
Measured by PET Scan
Time frame: 1 Hour
Renal Oxidative Metabolism
Measured by PET Scan
Time frame: 1 Hour
Blood Volume Fraction
Measured by PET Scan
Time frame: 1 Hour
Glomerular Basement Membrane Width
Measured by Renal Biopsy
Time frame: 1 Hour
Mesangial Expansion
Measured by Renal Biopsy
Time frame: 1 Hour
Interstitial Fibrosis
Measured by Renal Biopsy
Time frame: 1 Hour
Renal Arteriosclerosis
Measured by Renal Biopsy
Time frame: 1 Hour
Spatial Transcriptomics
Measured by Renal Biopsy
Time frame: 1 Hour
Spatial Metabolomics
Measured by Renal Biopsy
Time frame: 1 Hour
Pulse Wave Velocity between Carotid and Femoral Artery
Measured by PWV
Time frame: 10 minutes
Whole brain gray matter volume
Measured by brain MRI
Time frame: 1 Hour
Whole brain cortical thickness
Measured by brain MRI
Time frame: 1 Hour
Whole brain resting-state network connectivity
Measured by brain MRI
Time frame: 1 Hour
Age-corrected composite fluid cognition score
Measured by brain MRI
Time frame: 1 Hour
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.